Mode
Text Size
Log in / Sign up
N/A N=1 Supportive Care

Effects of Post-Stroke Upper Extremity Assistance

Arm Weakness as a Consequence of Stroke

Enrolled (actual)
1
Serious AEs
0.0%
Results posted
Oct 2023
Primary outcome: Primary: Wolf Motor Function Test - Change in Functional Score by Task (WMFT) — 7; 3; 5 Tasks

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Compliant Passive Arm Support (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Stanford University
Primary completion
Sep 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Wolf Motor Function Test - Change in Functional Score by Task (WMFT)
7; 3; 5
PRIMARY
Wolf Motor Function Test - Change in Completion Time by Task
3; 0; 12
PRIMARY
Wolf Motor Function Test - Weight Lifted
4.6; 6.1
PRIMARY
Percentage of Successful Motions
57.5; 69.84 0.02 sig
PRIMARY
Reachable Workspace - Mean Distance From Trunk, Successful Motions
-0.07; -0.05 0.01 sig
PRIMARY
Reachable Workspace - Area, Successful Motions
0.078; 0.082 0.48
PRIMARY
Reachable Workspace - Mean Distance From Trunk, All Motions
-0.14; -0.12
SECONDARY
Participant Satisfaction Survey
3; 4; 1; 1; 1; 4

Summary

The purpose of this study is to quantify the improvement of post- stroke individuals' ability to move their arms during and after robot assisted therapy. While researchers know that robot assisted therapies improve motor performance over the course of weeks, they do not know how motor performance is affected over the course of minutes or hours. A better understanding of how robot assisted therapies affect motor performance on short time scales may help us to prescribe more effective therapy doses to maximize motor recovery after neurological injury. The study will allow us to obtain a detailed understanding of the performance of the device as described above.

Eligibility Criteria

Inclusion Criteria

  • greater than 6 months post-stroke
  • passive abduction to 90 degrees at shoulder
  • reduced active (retro)flexion/extension at shoulder when abducted at 90 degrees
  • reduced active flexion/extension at elbow

Exclusion Criteria

  • unable to give informed consent
  • unable to comprehend and follow instructions
  • have a condition (other than stroke) affecting sensorimotor function
  • show evidence of unilateral spatial neglect
  • unable to sit in a chair without armrests for 2 hours
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05036642). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search